Fluicell had hardly finished installing a first system at the research and technology-specialised Technion – Israel Institute of Technology – before they had also sold an instrument to the prestigious Oxford University. Things are moving fast for the company in the Biotech Center @Sahlgrenska Science Park.
Fluicell develops instruments for drug analysis on a single cell level. This summer, the company started collaborating with the distribution partner New Bio Technology.
“Our collaboration has immediately shown good results on the Israeli market, and we are very proud to have another prestigious university like Technion – Israel Institute of Technology – as a BioPen customer,” says Victoire Vinnay, CEO of Fluciell.
The platform solution enables researchers to expose individual cells, parts of cells or tissues to very small amounts of drugs.
Oxford University is ranked as the leading university in the world. The physics department has one of the world’s most distinguished reputations, not least due to its advanced experimental research of life on all levels.
“The sale of Dynaflow Resolve to such a world-leading institution as Oxford University demonstrates the wide demand for instruments and platforms for single cell research. We see the market growing rapidly and, as pioneers in this niche, we feel we are very well positioned to meet the need, “says Victoire Viannay, CEO of Fluicell.
For more information, see fluicell.com or contact Victoire Vinnay, CEO, by phone +46 (0)725-65 42 05 or e-mail firstname.lastname@example.org.
Fluicell supports Rosa Bandet 2018.
Text: Annika Åkerval